| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 33 | 2021 | 575 | 4.630 |
Why?
|
| Kidney Neoplasms | 32 | 2024 | 3146 | 2.810 |
Why?
|
| Cryosurgery | 12 | 2021 | 186 | 2.440 |
Why?
|
| Carcinoma, Renal Cell | 21 | 2022 | 2413 | 1.990 |
Why?
|
| Surgery, Computer-Assisted | 8 | 2020 | 260 | 1.880 |
Why?
|
| Image-Guided Biopsy | 6 | 2024 | 337 | 1.430 |
Why?
|
| Radiography, Interventional | 17 | 2018 | 311 | 1.330 |
Why?
|
| Ablation Techniques | 7 | 2021 | 149 | 1.290 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 4 | 2024 | 106 | 1.160 |
Why?
|
| Chemoembolization, Therapeutic | 10 | 2011 | 192 | 0.890 |
Why?
|
| Tomography, X-Ray Computed | 43 | 2016 | 7784 | 0.880 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 421 | 0.780 |
Why?
|
| Laser Therapy | 3 | 2011 | 465 | 0.780 |
Why?
|
| Liver Neoplasms | 25 | 2022 | 4787 | 0.730 |
Why?
|
| Biopsy, Needle | 15 | 2016 | 1403 | 0.720 |
Why?
|
| Microwaves | 1 | 2020 | 33 | 0.710 |
Why?
|
| Electroporation | 1 | 2020 | 127 | 0.680 |
Why?
|
| Embolization, Therapeutic | 13 | 2020 | 605 | 0.650 |
Why?
|
| Bone Neoplasms | 8 | 2017 | 2668 | 0.640 |
Why?
|
| Renal Artery | 4 | 2016 | 92 | 0.630 |
Why?
|
| Hepatic Artery | 8 | 2011 | 256 | 0.620 |
Why?
|
| Diagnostic Imaging | 4 | 2021 | 1178 | 0.610 |
Why?
|
| Kidney | 8 | 2024 | 2339 | 0.590 |
Why?
|
| Musculoskeletal Diseases | 1 | 2018 | 95 | 0.580 |
Why?
|
| Nephrectomy | 9 | 2018 | 809 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2024 | 7950 | 0.560 |
Why?
|
| Treatment Outcome | 48 | 2021 | 33833 | 0.540 |
Why?
|
| Neoplasms, Second Primary | 3 | 2021 | 1379 | 0.520 |
Why?
|
| Lung Neoplasms | 13 | 2021 | 11758 | 0.510 |
Why?
|
| Postoperative Complications | 12 | 2021 | 5690 | 0.510 |
Why?
|
| Radiology, Interventional | 2 | 2015 | 142 | 0.490 |
Why?
|
| Ultrasonography, Interventional | 6 | 2008 | 417 | 0.420 |
Why?
|
| Muscle Neoplasms | 2 | 2011 | 108 | 0.420 |
Why?
|
| Aged, 80 and over | 33 | 2024 | 30937 | 0.390 |
Why?
|
| Humans | 112 | 2024 | 271076 | 0.390 |
Why?
|
| Chyle | 1 | 2011 | 22 | 0.390 |
Why?
|
| Aged | 62 | 2024 | 73177 | 0.380 |
Why?
|
| Hepatectomy | 6 | 2020 | 1012 | 0.370 |
Why?
|
| Osteotomy | 1 | 2011 | 101 | 0.360 |
Why?
|
| Mediastinal Diseases | 2 | 2008 | 58 | 0.350 |
Why?
|
| Chest Tubes | 5 | 2016 | 118 | 0.350 |
Why?
|
| Pneumothorax | 6 | 2016 | 165 | 0.350 |
Why?
|
| Male | 77 | 2024 | 128555 | 0.340 |
Why?
|
| Thermography | 1 | 2010 | 57 | 0.340 |
Why?
|
| Middle Aged | 66 | 2024 | 90070 | 0.340 |
Why?
|
| Urinary Bladder | 2 | 2011 | 600 | 0.320 |
Why?
|
| Portal Vein | 5 | 2020 | 364 | 0.320 |
Why?
|
| Retrospective Studies | 44 | 2024 | 39710 | 0.320 |
Why?
|
| Pleural Diseases | 1 | 2008 | 58 | 0.310 |
Why?
|
| Blood Pressure | 1 | 2014 | 1600 | 0.300 |
Why?
|
| Female | 71 | 2024 | 148608 | 0.300 |
Why?
|
| Precision Medicine | 1 | 2015 | 1201 | 0.300 |
Why?
|
| Adult | 53 | 2024 | 81614 | 0.290 |
Why?
|
| Intracranial Embolism | 1 | 2007 | 40 | 0.290 |
Why?
|
| Cytodiagnosis | 1 | 2008 | 227 | 0.290 |
Why?
|
| Catheterization, Central Venous | 2 | 2018 | 365 | 0.280 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2018 | 508 | 0.270 |
Why?
|
| Neoplasms, Experimental | 1 | 2010 | 791 | 0.270 |
Why?
|
| Lung Diseases | 2 | 2010 | 751 | 0.270 |
Why?
|
| Biopsy | 5 | 2021 | 3555 | 0.260 |
Why?
|
| Pneumothorax, Artificial | 1 | 2005 | 6 | 0.260 |
Why?
|
| Laparoscopy | 2 | 2014 | 1292 | 0.260 |
Why?
|
| Dogs | 5 | 2010 | 1205 | 0.250 |
Why?
|
| Aorta, Thoracic | 3 | 1999 | 532 | 0.250 |
Why?
|
| Pulmonary Embolism | 4 | 2019 | 333 | 0.250 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 342 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 9 | 2018 | 10349 | 0.240 |
Why?
|
| Colorectal Neoplasms | 5 | 2020 | 3657 | 0.240 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2024 | 698 | 0.240 |
Why?
|
| Osteoma, Osteoid | 1 | 2004 | 24 | 0.240 |
Why?
|
| Hypertension | 1 | 2014 | 1620 | 0.240 |
Why?
|
| Lung | 5 | 2021 | 3268 | 0.230 |
Why?
|
| Needles | 3 | 2015 | 107 | 0.230 |
Why?
|
| Catheters, Indwelling | 3 | 2018 | 383 | 0.220 |
Why?
|
| Hot Temperature | 1 | 2004 | 290 | 0.220 |
Why?
|
| von Hippel-Lindau Disease | 2 | 2018 | 123 | 0.220 |
Why?
|
| Models, Animal | 4 | 2007 | 675 | 0.210 |
Why?
|
| Sarcoma | 1 | 2013 | 1840 | 0.200 |
Why?
|
| Survival Rate | 12 | 2021 | 12519 | 0.200 |
Why?
|
| Aneurysm, False | 3 | 2016 | 143 | 0.200 |
Why?
|
| Vena Cava Filters | 2 | 2017 | 90 | 0.190 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2021 | 34 | 0.190 |
Why?
|
| Patient Selection | 6 | 2016 | 2043 | 0.190 |
Why?
|
| Disease Models, Animal | 4 | 2010 | 7464 | 0.190 |
Why?
|
| Subclavian Artery | 1 | 2001 | 79 | 0.190 |
Why?
|
| Neoplasms | 6 | 2017 | 15838 | 0.190 |
Why?
|
| Iatrogenic Disease | 1 | 2001 | 198 | 0.180 |
Why?
|
| Aortography | 2 | 1999 | 171 | 0.180 |
Why?
|
| Thorax | 1 | 2021 | 230 | 0.170 |
Why?
|
| Tumor Burden | 4 | 2020 | 2034 | 0.170 |
Why?
|
| Hepatic Veins | 1 | 2020 | 59 | 0.170 |
Why?
|
| Radiography | 8 | 2005 | 1989 | 0.170 |
Why?
|
| Aortic Rupture | 2 | 1999 | 116 | 0.170 |
Why?
|
| Evidence-Based Medicine | 3 | 2014 | 1062 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 2 | 1999 | 291 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 2426 | 0.160 |
Why?
|
| Ultrasonography | 2 | 2005 | 1934 | 0.160 |
Why?
|
| Societies, Medical | 2 | 2015 | 1348 | 0.160 |
Why?
|
| Musculoskeletal System | 1 | 2018 | 37 | 0.150 |
Why?
|
| Liver | 5 | 2020 | 3127 | 0.150 |
Why?
|
| Thoracic Injuries | 1 | 1998 | 99 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2008 | 2159 | 0.150 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1997 | 16 | 0.150 |
Why?
|
| CTLA-4 Antigen | 1 | 2021 | 667 | 0.150 |
Why?
|
| Colon, Descending | 1 | 2017 | 8 | 0.150 |
Why?
|
| Osteosarcoma | 1 | 2004 | 949 | 0.140 |
Why?
|
| Colon, Ascending | 1 | 2017 | 14 | 0.140 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2004 | 920 | 0.140 |
Why?
|
| Intussusception | 1 | 1997 | 52 | 0.140 |
Why?
|
| Colonic Diseases | 1 | 1997 | 74 | 0.140 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 5183 | 0.140 |
Why?
|
| Risk Factors | 9 | 2020 | 17835 | 0.140 |
Why?
|
| Stents | 5 | 2021 | 1006 | 0.140 |
Why?
|
| Indazoles | 2 | 2018 | 310 | 0.130 |
Why?
|
| Jejunostomy | 1 | 2016 | 57 | 0.130 |
Why?
|
| Portacaval Shunt, Surgical | 3 | 2005 | 6 | 0.130 |
Why?
|
| Liver Abscess | 1 | 2016 | 37 | 0.130 |
Why?
|
| Hemorrhage | 2 | 2014 | 742 | 0.130 |
Why?
|
| Equipment Design | 4 | 2016 | 1207 | 0.130 |
Why?
|
| Hydrogels | 1 | 2016 | 126 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2013 | 2670 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2013 | 1548 | 0.130 |
Why?
|
| Gastrointestinal Stromal Tumors | 2 | 2009 | 319 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1997 | 224 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2022 | 1269 | 0.120 |
Why?
|
| Metastasectomy | 1 | 2016 | 209 | 0.120 |
Why?
|
| Sympathectomy | 1 | 2014 | 16 | 0.120 |
Why?
|
| Venereal Tumors, Veterinary | 2 | 2005 | 11 | 0.120 |
Why?
|
| Urinary Fistula | 2 | 2004 | 34 | 0.120 |
Why?
|
| Feasibility Studies | 5 | 2010 | 2346 | 0.120 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2016 | 212 | 0.120 |
Why?
|
| Solitary Pulmonary Nodule | 3 | 2010 | 125 | 0.120 |
Why?
|
| Antineoplastic Agents | 6 | 2014 | 14678 | 0.120 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2004 | 29 | 0.120 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2007 | 111 | 0.110 |
Why?
|
| Genes, ras | 1 | 2017 | 680 | 0.110 |
Why?
|
| Yttrium Radioisotopes | 2 | 2005 | 210 | 0.110 |
Why?
|
| Cisplatin | 4 | 2004 | 2493 | 0.110 |
Why?
|
| Consensus | 2 | 2019 | 1106 | 0.110 |
Why?
|
| Hemostatics | 1 | 2014 | 82 | 0.110 |
Why?
|
| Urologic Diseases | 1 | 2014 | 84 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 6165 | 0.110 |
Why?
|
| Leukemia, Myeloid | 1 | 1998 | 994 | 0.110 |
Why?
|
| Computer Systems | 1 | 2013 | 117 | 0.110 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 223 | 0.110 |
Why?
|
| Combined Modality Therapy | 5 | 2021 | 9042 | 0.110 |
Why?
|
| Mitomycin | 2 | 2004 | 215 | 0.110 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 15256 | 0.100 |
Why?
|
| Pyelonephritis | 1 | 2012 | 50 | 0.100 |
Why?
|
| Doxorubicin | 3 | 2004 | 3138 | 0.100 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2012 | 57 | 0.100 |
Why?
|
| Drug Resistance | 1 | 2014 | 616 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 366 | 0.100 |
Why?
|
| Urologic Neoplasms | 1 | 2014 | 209 | 0.100 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2012 | 61 | 0.100 |
Why?
|
| Carcinoid Tumor | 2 | 2005 | 281 | 0.100 |
Why?
|
| Pyrimidines | 2 | 2018 | 3667 | 0.100 |
Why?
|
| Pelvic Neoplasms | 2 | 2004 | 203 | 0.100 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2013 | 181 | 0.100 |
Why?
|
| Online Systems | 1 | 2011 | 26 | 0.100 |
Why?
|
| Time Factors | 7 | 2018 | 13130 | 0.100 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2009 | 623 | 0.100 |
Why?
|
| Adolescent | 13 | 2015 | 32595 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 2 | 2020 | 410 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 432 | 0.090 |
Why?
|
| Urine | 1 | 2011 | 149 | 0.090 |
Why?
|
| Risk Management | 1 | 2011 | 116 | 0.090 |
Why?
|
| Salvage Therapy | 2 | 2018 | 2117 | 0.090 |
Why?
|
| Fluoroscopy | 3 | 2008 | 223 | 0.090 |
Why?
|
| Kidney Function Tests | 4 | 2015 | 211 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 3398 | 0.090 |
Why?
|
| Texas | 4 | 2018 | 6417 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2011 | 249 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2011 | 304 | 0.080 |
Why?
|
| Prognosis | 7 | 2017 | 22463 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2018 | 1922 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 327 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2018 | 1370 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 1437 | 0.080 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 1237 | 0.080 |
Why?
|
| Hyperthermia, Induced | 1 | 2013 | 510 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2012 | 344 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2021 | 2851 | 0.080 |
Why?
|
| Renal Dialysis | 2 | 2007 | 946 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 2010 | 259 | 0.080 |
Why?
|
| Ureteral Diseases | 2 | 2004 | 19 | 0.080 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 2 | 2004 | 24 | 0.070 |
Why?
|
| Imidazoles | 1 | 2014 | 1060 | 0.070 |
Why?
|
| Pain Management | 2 | 2012 | 716 | 0.070 |
Why?
|
| Disease-Free Survival | 6 | 2020 | 10250 | 0.070 |
Why?
|
| Kyphosis | 2 | 2004 | 45 | 0.070 |
Why?
|
| Risk Assessment | 4 | 2019 | 6837 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 56 | 0.070 |
Why?
|
| Bone Cements | 2 | 2004 | 49 | 0.070 |
Why?
|
| Adenoviridae | 2 | 2003 | 1510 | 0.070 |
Why?
|
| Pneumonectomy | 1 | 2013 | 863 | 0.070 |
Why?
|
| Splenic Neoplasms | 1 | 2008 | 125 | 0.070 |
Why?
|
| Carotid Artery, Common | 1 | 2007 | 94 | 0.070 |
Why?
|
| Thrombin | 1 | 2007 | 93 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2007 | 101 | 0.070 |
Why?
|
| Angioplasty | 1 | 2007 | 83 | 0.070 |
Why?
|
| Disease Management | 1 | 2013 | 1111 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2007 | 77 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2014 | 802 | 0.070 |
Why?
|
| Hepatic Encephalopathy | 2 | 2004 | 89 | 0.070 |
Why?
|
| Palliative Care | 4 | 2021 | 2152 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 606 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2010 | 729 | 0.070 |
Why?
|
| Animals | 11 | 2010 | 62871 | 0.070 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2005 | 35 | 0.070 |
Why?
|
| Logistic Models | 2 | 2011 | 3437 | 0.060 |
Why?
|
| Splenic Artery | 1 | 2005 | 53 | 0.060 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2005 | 373 | 0.060 |
Why?
|
| Splenic Diseases | 1 | 2005 | 60 | 0.060 |
Why?
|
| Hematologic Neoplasms | 2 | 2010 | 1955 | 0.060 |
Why?
|
| Carcinoma | 1 | 2017 | 2627 | 0.060 |
Why?
|
| Electrodes | 1 | 2005 | 126 | 0.060 |
Why?
|
| Leg Bones | 1 | 2004 | 10 | 0.060 |
Why?
|
| Dog Diseases | 1 | 2005 | 76 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5516 | 0.060 |
Why?
|
| Radius | 1 | 2004 | 44 | 0.060 |
Why?
|
| Humerus | 1 | 2004 | 50 | 0.060 |
Why?
|
| HT29 Cells | 1 | 2004 | 157 | 0.060 |
Why?
|
| Outpatients | 1 | 2007 | 470 | 0.060 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2006 | 199 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2020 | 159 | 0.060 |
Why?
|
| Drug Carriers | 1 | 2005 | 336 | 0.060 |
Why?
|
| Vascular Fistula | 1 | 2004 | 34 | 0.060 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2003 | 39 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2004 | 151 | 0.060 |
Why?
|
| Melanoma | 2 | 2011 | 5524 | 0.060 |
Why?
|
| Child | 8 | 2015 | 30421 | 0.060 |
Why?
|
| Young Adult | 4 | 2021 | 22062 | 0.050 |
Why?
|
| Research Design | 1 | 2010 | 1568 | 0.050 |
Why?
|
| Spleen | 1 | 2005 | 736 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 3176 | 0.050 |
Why?
|
| Swine | 5 | 2007 | 1610 | 0.050 |
Why?
|
| Radiography, Abdominal | 1 | 2004 | 123 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2005 | 1567 | 0.050 |
Why?
|
| Femoral Vein | 1 | 2003 | 64 | 0.050 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2007 | 705 | 0.050 |
Why?
|
| Spine | 1 | 2004 | 311 | 0.050 |
Why?
|
| Bandages | 1 | 2003 | 76 | 0.050 |
Why?
|
| Back Pain | 1 | 2003 | 63 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2014 | 3972 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 473 | 0.050 |
Why?
|
| Steel | 1 | 2021 | 10 | 0.050 |
Why?
|
| Pelvis | 1 | 2003 | 384 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 250 | 0.050 |
Why?
|
| Spinal Fractures | 1 | 2003 | 139 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2017 | 16592 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 588 | 0.050 |
Why?
|
| Mediastinal Neoplasms | 1 | 2005 | 429 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 744 | 0.050 |
Why?
|
| Pancreatic Diseases | 1 | 2002 | 112 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 378 | 0.050 |
Why?
|
| Quality of Life | 3 | 2018 | 4725 | 0.050 |
Why?
|
| Pain | 2 | 2012 | 1692 | 0.050 |
Why?
|
| Piperazines | 1 | 2009 | 2153 | 0.050 |
Why?
|
| Liver Diseases | 2 | 2004 | 606 | 0.050 |
Why?
|
| Microspheres | 3 | 2005 | 240 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 5188 | 0.040 |
Why?
|
| Incidence | 3 | 2017 | 5845 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2003 | 358 | 0.040 |
Why?
|
| Neuroendocrine Tumors | 1 | 2006 | 651 | 0.040 |
Why?
|
| Anilides | 1 | 2022 | 295 | 0.040 |
Why?
|
| Survival Analysis | 4 | 2017 | 9309 | 0.040 |
Why?
|
| Disease Progression | 3 | 2018 | 6896 | 0.040 |
Why?
|
| Lymphoma | 1 | 2008 | 1516 | 0.040 |
Why?
|
| Retreatment | 1 | 2020 | 451 | 0.040 |
Why?
|
| Rupture | 1 | 1998 | 57 | 0.040 |
Why?
|
| Multidetector Computed Tomography | 1 | 2020 | 148 | 0.040 |
Why?
|
| Cryotherapy | 1 | 2018 | 68 | 0.040 |
Why?
|
| Epidemiologic Methods | 2 | 2009 | 252 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2003 | 1135 | 0.040 |
Why?
|
| Cost Control | 1 | 2018 | 45 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 4956 | 0.040 |
Why?
|
| Cecal Diseases | 1 | 1997 | 13 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 872 | 0.040 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2007 | 78 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2004 | 4902 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 219 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1999 | 143 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 5835 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 1998 | 276 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 15855 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 5989 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 1312 | 0.030 |
Why?
|
| Patient Safety | 1 | 2021 | 651 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 5324 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2007 | 113 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 5411 | 0.030 |
Why?
|
| Ultrasonography, Mammary | 1 | 1998 | 386 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 5087 | 0.030 |
Why?
|
| Arthralgia | 1 | 2016 | 97 | 0.030 |
Why?
|
| Renal Veins | 2 | 2007 | 63 | 0.030 |
Why?
|
| Margins of Excision | 1 | 2017 | 314 | 0.030 |
Why?
|
| Pyridines | 1 | 2022 | 1312 | 0.030 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 13975 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2016 | 307 | 0.030 |
Why?
|
| Thoracic Surgical Procedures | 1 | 1998 | 261 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 1997 | 380 | 0.030 |
Why?
|
| Safety | 2 | 2007 | 466 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 372 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 9434 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 4840 | 0.030 |
Why?
|
| Hypertension, Portal | 2 | 2005 | 129 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 1998 | 16184 | 0.030 |
Why?
|
| Vascular Patency | 2 | 2005 | 191 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 2521 | 0.030 |
Why?
|
| Recurrence | 2 | 2003 | 4885 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 774 | 0.030 |
Why?
|
| Contrast Media | 1 | 2020 | 1510 | 0.030 |
Why?
|
| Medical Records | 2 | 2005 | 443 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 202 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1998 | 615 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 826 | 0.030 |
Why?
|
| Urothelium | 1 | 2014 | 272 | 0.030 |
Why?
|
| ras Proteins | 1 | 2017 | 803 | 0.030 |
Why?
|
| Diarrhea | 1 | 2016 | 732 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6249 | 0.030 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 1335 | 0.030 |
Why?
|
| Prosthesis Design | 2 | 2005 | 662 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 4124 | 0.020 |
Why?
|
| Systems Integration | 1 | 2011 | 79 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2018 | 13353 | 0.020 |
Why?
|
| Algorithms | 2 | 2017 | 3909 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2003 | 2322 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 2984 | 0.020 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2010 | 17 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2018 | 917 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 2373 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 3657 | 0.020 |
Why?
|
| United States | 2 | 2018 | 15989 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2010 | 75 | 0.020 |
Why?
|
| Health Services Research | 1 | 2011 | 243 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 4332 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 325 | 0.020 |
Why?
|
| Lung Diseases, Fungal | 1 | 2010 | 133 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 567 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 306 | 0.020 |
Why?
|
| Nephrons | 1 | 2008 | 49 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 4982 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 3543 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 4968 | 0.020 |
Why?
|
| Auscultation | 1 | 2007 | 8 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2010 | 277 | 0.020 |
Why?
|
| Radiotherapy Dosage | 2 | 2005 | 4001 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2007 | 166 | 0.020 |
Why?
|
| Medical Audit | 1 | 2008 | 196 | 0.020 |
Why?
|
| Radiotherapy | 2 | 2005 | 1858 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2007 | 288 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2009 | 641 | 0.020 |
Why?
|
| Angiography | 1 | 2007 | 344 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 721 | 0.020 |
Why?
|
| Imatinib Mesylate | 1 | 2009 | 1691 | 0.020 |
Why?
|
| Portal Pressure | 1 | 2005 | 13 | 0.020 |
Why?
|
| Polyvinyl Alcohol | 1 | 2005 | 22 | 0.020 |
Why?
|
| Aneurysm | 1 | 2005 | 91 | 0.020 |
Why?
|
| Gelatin | 1 | 2005 | 42 | 0.020 |
Why?
|
| Urinary Bladder Fistula | 1 | 2004 | 14 | 0.020 |
Why?
|
| Acrylic Resins | 1 | 2005 | 49 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 1156 | 0.020 |
Why?
|
| Phlebography | 1 | 2005 | 67 | 0.020 |
Why?
|
| Genetic Therapy | 2 | 2003 | 1732 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2005 | 237 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 1326 | 0.020 |
Why?
|
| Hematocrit | 1 | 2005 | 157 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2005 | 100 | 0.020 |
Why?
|
| Hydrothorax | 1 | 2004 | 18 | 0.010 |
Why?
|
| Urethral Diseases | 1 | 2004 | 39 | 0.010 |
Why?
|
| Ethanol | 1 | 2006 | 270 | 0.010 |
Why?
|
| Tomography, Spiral Computed | 1 | 2005 | 128 | 0.010 |
Why?
|
| Varicose Veins | 1 | 2004 | 31 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1883 | 0.010 |
Why?
|
| Ilium | 1 | 2004 | 54 | 0.010 |
Why?
|
| Floxuridine | 1 | 2003 | 41 | 0.010 |
Why?
|
| Hemoperitoneum | 1 | 2003 | 11 | 0.010 |
Why?
|
| Osteolysis | 1 | 2004 | 99 | 0.010 |
Why?
|
| Ascites | 1 | 2004 | 217 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 2003 | 43 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2005 | 579 | 0.010 |
Why?
|
| Wounds, Penetrating | 1 | 2004 | 157 | 0.010 |
Why?
|
| Reoperation | 1 | 2007 | 1390 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2003 | 176 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2005 | 485 | 0.010 |
Why?
|
| Jugular Veins | 1 | 2003 | 113 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 2003 | 190 | 0.010 |
Why?
|
| Immobilization | 1 | 2003 | 91 | 0.010 |
Why?
|
| Hemostasis | 1 | 2003 | 99 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2003 | 167 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2003 | 169 | 0.010 |
Why?
|
| Contraindications | 1 | 2002 | 156 | 0.010 |
Why?
|
| Vinblastine | 1 | 2003 | 462 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 991 | 0.010 |
Why?
|
| Fractures, Spontaneous | 1 | 2003 | 86 | 0.010 |
Why?
|
| Leucovorin | 1 | 2003 | 343 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2003 | 189 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 1836 | 0.010 |
Why?
|
| Platelet Count | 1 | 2003 | 490 | 0.010 |
Why?
|
| Body Height | 1 | 2003 | 232 | 0.010 |
Why?
|
| Cause of Death | 1 | 2005 | 785 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 978 | 0.010 |
Why?
|
| Endosonography | 1 | 2005 | 549 | 0.010 |
Why?
|
| Thrombosis | 1 | 2007 | 751 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2006 | 1740 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 2005 | 494 | 0.010 |
Why?
|
| Brachytherapy | 1 | 2006 | 1005 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 812 | 0.010 |
Why?
|
| Intestines | 1 | 2004 | 731 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2003 | 690 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2008 | 16981 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2007 | 2044 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 4984 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2003 | 1984 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1999 | 117 | 0.010 |
Why?
|
| Length of Stay | 1 | 2005 | 2013 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2006 | 1185 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2003 | 663 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 1884 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2010 | 3145 | 0.010 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2004 | 1449 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 3654 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 3866 | 0.010 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1999 | 519 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 6492 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 5233 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 7938 | 0.000 |
Why?
|
| Apoptosis | 1 | 2003 | 7852 | 0.000 |
Why?
|